Ozanimod Hydrochloride is an immunomodulator and selective sphingosine-1-phosphate (S1P) receptor modulator primarily used in the treatment of relapsing forms of multiple sclerosis and moderately to severely… Read more
Ozanimod Hydrochloride is an immunomodulator and selective sphingosine-1-phosphate (S1P) receptor modulator primarily used in the treatment of relapsing forms of multiple sclerosis and moderately to severely active ulcerative colitis. By targeting specific S1P1 and S1P5 receptors, the medication helps regulate lymphocyte trafficking to mitigate inflammatory processes. To support the rigorous analytical testing and quality control required for this drug substance, pharmaceutical laboratories rely on high-quality reference standards. This category includes the active pharmaceutical ingredient, alongside essential impurities, metabolites, and stable isotope labelled compounds. These materials are vital for conducting accurate impurity profiling, method validation, and the precise quantification of drug substances in complex matrices. Utilizing these well-characterized reference standards enables analysts to ensure regulatory compliance, confirm compound identity, and verify the consistency of drug products throughout the pharmaceutical development and manufacturing process.